4//SEC Filing
BAYS F BARRY 4
Accession 0001209191-23-021741
CIK 0001630627other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 9:00 PM ET
Size
7.2 KB
Accession
0001209191-23-021741
Insider Transaction Report
Form 4
BAYS F BARRY
Director
Transactions
- Sale
Common Stock
2023-03-29$25.28/sh−32,457$820,425→ 1,204,785 total - Sale
Common Stock
2023-03-28$25.02/sh−26,241$656,650→ 1,237,242 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.8800 to $25.1600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0900 to $25.5600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001183554
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 9:00 PM ET
- Size
- 7.2 KB